IQGAP1 and pancreatic neoplasm: KRAS mutations activate ARL4C, which recruits MMP14 via its interaction with IQGAP1, forming invasive pseudopodia that contribute to the uncontrolled invasion and metastasis of pancreatic cancer (58).